NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Chairman and CEO Thomas A. Moore of Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) biotechnology company, was interviewed by William Dawson of LifeTech Capital at the 2010 OneMedForum biotechnology conference last month in San Francisco, CA. To view the interview, please visit the following websites/hotlinks:
